Health & Safety

July 9, 2012

Neurotrauma, Psychological Health office partners with VA to study PTSD treatments

by Carey Phillips
Fort Detrick, Md.

Post-traumatic stress disorder is a common anxiety disorder that can stem from any traumatic event experienced by an individual.

While there are medications currently approved by the U.S. Food and Drug Administration to treat it, they are not sufficiently effective in treating combat-related post-traumatic stress commonly seen in service members and veterans.

The U.S. Army Medical Materiel Development Activity’s Neurotrauma and Psychological Health Project Management Office signed an interagency agreement with the Veterans Affairs Cooperative Studies Program, or VACSP, to jointly conduct and support clinical studies of pharmacotherapeutics for the treatment of combat-related Post-traumatic stress disorder, knowns as PTSD, in service members and veterans.

“The interagency agreement between USAMMDA and VACSP structures how the agencies will collaborate,” said Maj. Gary Wynn, research psychiatrist with the Neurotrauma and Psychological Health Project Management Office. “While the DOD may be funding the research effort, the VA is an equal partner in the project.”

“The VA is the primary location for Veterans to receive care so we need to be looking at their populations as well as those still on active duty,” he explained.

USAMMDA and VACSP will be working together to identify and develop alternate indications for existing FDA-approved drugs used to treat other disorders.

“While these drugs are FDA-approved, they are not approved for the treatment of PTSD,” said Wynn. “In fact, many of the drugs currently being used have little, or no research supporting their off-label use in treating PTSD.”

Currently, there are two drugs that are FDA-approved for treating PTSD. However, studies have shown that these drugs are less than 50 percent effective when it comes to treating combat-related PTSD. Additionally, the side effects from these drugs can be harmful to service members and veterans.

Although these drugs have helped victims of PTSD, worldwide they have shown limited benefit for service members and veterans struggling with the aftermath of combat.

“These studies are vital to understand if and how [the drugs in the collaborative USAMMDA and VACSP study] should be used in service members and veterans,” said Wynn.

According to Wynn, the collaboration between USAMMDA and the VA will ensure the highest quality of research.




All of this week's top headlines to your email every Friday.


 
 

 

Headlines August 1, 2015

News: Marine F-35 jets deemed ready for combat – A small batch of the highly anticipated – and much criticized – F-35B Joint Strike Fighter jets have been approved for combat by the U.S. Marine Corps.   News: Reports: China to sell J-10 fighter to Iran, Syria? – Iran is rumored external link to be buying 150...
 
 

News Briefs August 3, 2015

Russian military helicopter crashes during air show, one dead A Russian military helicopter crashed Aug. 2 during an aerobatic display, killing one of its crewmembers and injuring another, the Defense Ministry said. The Mi-28 helicopter gunship was part of a flight of helicopters performing aerobatics at the Dubrovichi firing range in Ryazan region, about 170...
 
 
Army photograph by John Andrew Hamilton

Improved Multiple Launch Rocket System tested at White Sands Missile Range

Army photograph by John Andrew Hamilton A Multiple Launch Rocket System with an improved armored cab fires a training rocket during a test. The rockets were simple training rockets and not equipped with a warhead, but still gen...
 

 

Missile Defense Agency, Raytheon demonstrate SM-6’s new anti-ballistic missile defense capability

In a first-of-its-kind test, the U.S. Navy fired a Raytheon Standard Missile-6, intercepting and destroying a short-range ballistic missile target at sea. The successful U.S. Missile Defense Agency test proved a modified SM-6 can eliminate threat ballistic missiles in their final seconds of flight. “SM-6 is the only missile in the world that can do...
 
 

Northrop Grumman-developed stealthy data link validated as combat ready with U.S. Marine Corps

the U.S. Marine Corps achieving F-35B initial operating capability, the Multifunction Advanced Data Link waveform developed by Northrop Grumman has been proven a key combat-ready capability of the F-35 Lightning II program. MADL is a high-data-rate, directional communications link that allows fifth-generation aircraft to communicate and coordinate tactics covertly. During testing of the Lockhee...
 
 

Lockheed Martin technology helps pilots, UAS operators share data, stay safe

As Unmanned Aircraft Systems take to the skies, it is essential for safety that UAS operators and pilots are aware of each other. To help provide this shared situational awareness, Lockheed Martin has deployed the first components of a UAS traffic management system that is available to the UAS community now. Lockheed Martin’s online Flight...
 




0 Comments


Be the first to comment!


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>